NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Harvard Psychiatrists Primed For a Fall
The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…
Research Protection for Children
AHRP Campaign to Protect Children from Harm Oct 15: FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical Deception Sep 30: GSK Sales Reps told NOT to Divulge Paxill Data…
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086 New York, NY 10023 www.ahrp.org November 1, 2004 Thomas W. Abrams Director Office…
Congress & the White House must remedy a prescription for danger – LA Times / CBS News
Congress & the White House must remedy a prescription for danger – LA Times / CBS News Thu, 1 Apr 2004 For those who missed the CBS evening News broadcast (Tues March 30) about FDA’s suppression of evidence, a video of that powerful report can be viewed online. http://www.cbsnews.com/stories/2004/03/30/eveningnews/main609491.shtml CBS…
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ Fri, 9 Jul 2004 A front page article in The Wall Street Journal exposes another case of safety data suppression by the FDA. The case involves a device to repair the heart artery which FDA’s…
Which is it—51 or 186 deaths linked to ADHD drugs?
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way: